Results 131 to 140 of about 384,012 (260)

Automated and Interpretable Patient ECG Profiles for Disease Detection, Tracking, and Discovery

, 2018
The electrocardiogram or ECG has been in use for over 100 years and remains the most widely performed diagnostic test to characterize cardiac structure and electrical activity.
Delling, Francesca N., Deo, Rahul C., Tison, Geoffrey H., Zhang, Jeffrey   +3 more
core   +1 more source

HYPERTROPHIC CARDIOMYOPATHY MIMICKING AMYLOID CARDIOMYOPATHY

Journal of the American College of Cardiology, 2021
Syed Bukhari, Ricardo Nieves, Shumail Fatima, Arun Iyer, Prem Soman   +4 more
openaire   +1 more source

BSE-associated Prion-Amyloid Cardiomyopathy in Primates

Emerging Infectious Diseases, 2013
Prion amyloidosis occurred in the heart of 1 of 3 macaques intraperitoneally inoculated with bovine spongiform encephalopathy prions. This macaque had a remarkably long duration of disease and signs of cardiac distress. Variant Creutzfeldt-Jakob disease, caused by transmission of bovine spongiform encephalopathy to humans, may manifest with cardiac ...
Krasemann, Susanne, Mearini, Giulia, Krämer, Elisabeth, Wagenführ, Katja, Schulz-Schaeffer, Walter, Neumann, Melanie, Bodemer, Walter, Kaup, Franz-Josef, Beekes, Michael, Carrier, Lucie, Aguzzi, Adriano, Glatzel, Markus   +11 more
openaire   +6 more sources

Multiparametric Monitoring of Disease Progression in Contemporary Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Initiating Tafamidis Treatment

Journal of Clinical Medicine
Background: Recently, a disease modifying therapy has become available for transthyretin amyloid cardiomyopathy (ATTR-CM). A validated monitoring concept of treatment is lacking, but a current expert consensus recommends three clinical domains (clinical,
Svenja Ney, R. Gertz, L. Pennig, R. Nies, U. Holtick, L. Völker, Gilbert Wunderlich, K. Seuthe, Christopher Hohmann, C. Metze, C. P. Nähle, J. von Stein, Monique Brüwer, H. ten Freyhaus, R. Pfister   +14 more
semanticscholar   +1 more source

Effect of long‐term tafamidis treatment on health‐related quality of life in patients with transthyretin amyloid cardiomyopathy

European Journal of Heart Failure
To evaluate the effect of long‐term tafamidis treatment on health‐related quality of life (HRQoL) in patients with transthyretin amyloid cardiomyopathy (ATTR‐CM) enrolled in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐
M. Grogan, Margot K Davis, M. Crespo-Leiro, M. Sultan, B. Gundapaneni, Franca Stedile Angeli, Mazen Hanna   +6 more
semanticscholar   +1 more source

Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness

The International Journal of Cardiovascular Imaging
Amyloid cardiomyopathy (CA) was previously considered a rare disease; however, rapid advancements in imaging modalities have led to an increased frequency of its diagnosis.
K. Holcman, M. Kostkiewicz, W. Szot, Bogdan Ćmiel, Krystian Mróz, A. Stępień, K. Graczyk, E. Dziewięcka, A. Karabinowska-Małocha, Z. Sachajko, Piotr Podolec, P. Rubis   +11 more
semanticscholar   +1 more source

International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction

Amyloid: Journal of Protein Folding Disorders
Background Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of heart failure (HF). Methods This epidemiology study assessed the international prevalence of ATTR-CM among patients aged ≥60 years with a history of HF, left ...
S. Yun, G. Palladini, L J Anderson, E. Cariou, Ronnie Wang, F. Angeli, B. Ebede, P. García-Pavía   +7 more
semanticscholar   +1 more source

Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study

Journal of Clinical Medicine
Background: Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) represent a high-risk heart failure population with continued unmet therapeutic needs.
N. Schwegel, C. Toferer, D. Zach, V. Santner, Viktoria Höller, J. Lugitsch, M. Wallner, J. Gollmer, F. Aziz, D. von Lewinski, E. Kolesnik, K. Ablasser, A. Zirlik, H. Sourij, N. Verheyen   +14 more
semanticscholar   +1 more source

Amyloid Cardiomyopathy ∗

Journal of the American College of Cardiology, 2016
Merrill D, Benson, Noel R, Dasgupta
openaire   +2 more sources

Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients

ESC Heart Failure
Transthyretin amyloid cardiomyopathy (ATTR‐CM) is characterized by increased wall thickness, diastolic dysfunction and progressive heart failure symptoms.
E. Aaseth, J. Christiansen
semanticscholar   +1 more source